Veterinary Medicines

COCCIBAL 200 MG/ML SOLUTION FOR USE IN DRINKING WATER FOR CHICKENS AND TURKEYS

Authorised
  • Amprolium hydrochloride
Download as PDF

Product identification

Medicine name:
COCCIBAL 200 MG/ML SOLUTION FOR USE IN DRINKING WATER FOR CHICKENS AND TURKEYS
Coccibal, 200 mg/ml oplossing voor gebruik in drinkwater voor kippen en kalkoenen
Active substance:
  • Amprolium hydrochloride
Target species:
  • Turkey
  • Chicken (pullet for egg production, future layer)
  • Chicken (for reproduction)
  • Chicken (broiler)
  • Chicken (layer hen)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amprolium hydrochloride
    226.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Turkey
      • Meat and offal
        0
        day
      • Eggs
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (layer hen)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BX02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • 1 L bottle
  • Box of 10 bottles of 100 mL
  • Box of 4 barrels of 5 L
  • Box of 12 bottles of 1 L
  • 5 L barrel

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • S P Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • S P Veterinaria S.A.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 121611
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0230/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 11/09/2025
Download